Three Months ended
|
||||||||||||
April 28,
2024
|
January 28,
2024
|
April 30,
2023
|
||||||||||
Reconciliation of GAAP to Non-GAAP Net Income:
|
||||||||||||
GAAP Net Income
|
$
|
36,251
|
$
|
26,180
|
$
|
39,929
|
||||||
FX (gain) loss
|
(14,766
|
)
|
8,909
|
(10,718
|
)
|
|||||||
Estimated tax effects of above
|
3,743
|
(2,244
|
)
|
2,823
|
||||||||
Estimated noncontrolling interest effects of above
|
3,489
|
(2,939
|
)
|
901
|
||||||||
Non-GAAP Net Income
|
$
|
28,717
|
$
|
29,906
|
$
|
32,935
|
||||||
Weighted-average number of common shares outstanding - Diluted
|
62,409
|
62,283
|
61,507
|
|||||||||
Reconciliation of GAAP to Non-GAAP EPS:
|
||||||||||||
GAAP diluted earnings per share
|
$
|
0.58
|
$
|
0.42
|
$
|
0.65
|
||||||
Effects of the above adjustments
|
$
|
(0.12
|
)
|
$
|
0.06
|
$
|
(0.11
|
)
|
||||
Non-GAAP diluted earnings per share
|
$
|
0.46
|
$
|
0.48
|
$
|
0.54
|